Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Humacyte (HUMA) Accumulated Depreciation & Amortization (2024 - 2025)

Humacyte has reported Accumulated Depreciation & Amortization over the past 2 years, most recently at $41.3 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $41.3 million for Q4 2025, up 14.53% from a year ago — trailing twelve months through Dec 2025 was $41.3 million (up 14.53% YoY), and the annual figure for FY2025 was $41.3 million, up 14.53%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $41.3 million at Humacyte, up from $40.1 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for HUMA hit a ceiling of $41.3 million in Q4 2025 and a floor of $32.6 million in Q1 2024.